Suppr超能文献

外显子组测序作为一线检测手段用于严重中枢神经系统结构异常的胎儿。

Exome sequencing as first-tier test for fetuses with severe central nervous system structural anomalies.

机构信息

Prenatal Genetic Diagnosis Unit, Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Ultrasound Obstet Gynecol. 2022 Jul;60(1):59-67. doi: 10.1002/uog.24885.

Abstract

OBJECTIVE

Prenatally detected central nervous system (CNS) anomalies present a diagnostic challenge. In this study, we compared the diagnostic yield of exome sequencing (ES) and chromosomal microarray analysis (CMA) in fetuses with a major CNS anomaly.

METHODS

This was a retrospective study of 114 cases referred for genetic evaluation following termination of pregnancy (TOP) due to a major CNS anomaly detected on prenatal ultrasound. All fetuses were first analyzed by CMA. All CMA-negative cases were offered ES. CMA-positive cases were reanalyzed using ES to assess its ability to detect copy-number variants (CNVs).

RESULTS

CMA identified a pathogenic or likely pathogenic (P/LP) CNV in 11/114 (10%) cases. Eighty-six CMA-negative cases were analyzed using ES, which detected P/LP sequence variants in 38/86 (44%). Among recurrent cases (i.e. cases with a previously affected pregnancy), the incidence of P/LP sequence variants was non-significantly higher compared with non-recurrent ones (12/19 (63%) vs 26/67 (39%); P = 0.06). Among the 38 cases with an ES diagnosis, 20 (53%) were inherited and carried a significant risk of recurrence. Reanalysis of 10 CMA-positive cases by ES demonstrated that the bioinformatics pipeline used for sequence variant analysis also detected all P/LP CNVs, as well as three previously known non-causative CNVs.

CONCLUSIONS

In our study, ES provided a high diagnostic yield (> 50%) in fetuses with severe CNS structural anomalies, which may have been partly due to the highly selected case series that included post-TOP cases from a specialist referral center. These data suggest that ES may be considered as a first-tier test for the prenatal diagnosis of major fetal CNS anomalies, detecting both P/LP sequence variants and CNVs. This is of particular importance given the time constraints of an ongoing pregnancy and the risk of recurrence in future pregnancies. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

摘要

目的

产前检出的中枢神经系统(CNS)异常具有诊断挑战性。本研究比较了大片段基因组重排测序(ES)和染色体微阵列分析(CMA)在胎儿 CNS 主要畸形中的诊断效能。

方法

这是一项回顾性研究,纳入 114 例因产前超声检出 CNS 主要畸形而终止妊娠(TOP)后行遗传评估的胎儿。所有胎儿均首先行 CMA 分析,CMA 阴性者行 ES 检查。CMA 阳性者行 ES 再分析以评估其检测拷贝数变异(CNV)的能力。

结果

CMA 在 114 例胎儿中检出 11 例(10%)致病性或疑似致病性(P/LP)CNV。86 例 CMA 阴性胎儿行 ES 检查,检出 38 例(44%)P/LP 序列变异。在复发性病例(即曾有受累妊娠的病例)中,P/LP 序列变异的发生率显著高于非复发性病例(12/19 [63%] 比 26/67 [39%];P=0.06)。在 38 例 ES 诊断病例中,20 例(53%)为遗传所致,具有显著的再发风险。10 例 CMA 阳性病例的 ES 再分析显示,用于序列变异分析的生物信息学分析流程也可检出所有 P/LP CNV 以及 3 例已知的非致病性 CNV。

结论

在本研究中,ES 在严重 CNS 结构畸形胎儿中提供了高的诊断率(>50%),这可能部分归因于该研究纳入了来自专科转诊中心的 TOP 后病例这一高度选择的病例系列。这些数据表明,ES 可考虑作为产前诊断胎儿 CNS 主要畸形的一线检查方法,可同时检出 P/LP 序列变异和 CNV。鉴于妊娠期间的时间限制和未来妊娠中再发的风险,这一点尤其重要。 © 2022 作者。超声在妇产科由约翰威立父子公司出版代表国际妇产科超声学会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c964/9328397/119d9dc29ba6/UOG-60-59-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验